Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coughlin Stoia Geller Rudman & Robbins LLP
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Elan Corporation plc
November 2nd, 2008
Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the Southern District of New York on behalf of purchasers of Elan Corporation plc ("Elan") (NYSE:ELN) publicly traded stock or American Depository Receipts ("ADRs") during the period between June 17, 2008 and July 29, 2008 (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to discuss this action or have any questions concerning this notice or your rights or...
Source: Pharma Investments, Ventures & Law Weekly (2008-11-02)
|
